ZYLOX-TONBRDG.MED.TECH.H1 Market Cap ($708.79 Million)
Market Cap & Net Worth: ZYLOX-TONBRDG.MED.TECH.H1 (818)
ZYLOX-TONBRDG.MED.TECH.H1 market cap. ZYLOX-TONBRDG.MED.TECH.H1 (F:818) has a market capitalization of $708.79 Million (€606.27 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #10189 globally and #1229 in its home market, demonstrating a -21.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ZYLOX-TONBRDG.MED.TECH.H1's stock price €1.88 by its total outstanding shares 323428113 (323.43 Million). Also see 818 operating cash flow for how efficiently the company converts equity into cash flow.
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap History (2021–2026)
ZYLOX-TONBRDG.MED.TECH.H1 market cap history from 2021 to 2026. Data shows change from $967.99 Million to $710.87 Million (-20.17% CAGR). Check 818 stock price for real-time trading data and today's change.
ZYLOX-TONBRDG.MED.TECH.H1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ZYLOX-TONBRDG.MED.TECH.H1 (818) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.63x
ZYLOX-TONBRDG.MED.TECH.H1's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.90x
ZYLOX-TONBRDG.MED.TECH.H1's market cap is 4.90 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $967.99 Million | $177.91 Million | -$199.69 Million | 5.44x | N/A |
| 2022 | $555.84 Million | $334.09 Million | -$113.56 Million | 1.66x | N/A |
| 2023 | $518.03 Million | $527.75 Million | -$78.73 Million | 0.98x | N/A |
| 2024 | $491.56 Million | $782.48 Million | $100.26 Million | 0.63x | 4.90x |
Competitor Companies of 818 by Market Capitalization
Companies near ZYLOX-TONBRDG.MED.TECH.H1 in the global market cap rankings as of November 4, 2026. Also see 818 total asset value for a full breakdown of the balance sheet.
Key companies related to ZYLOX-TONBRDG.MED.TECH.H1 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of ZYLOX-TONBRDG.MED.TECH.H1 (2021–2026)
Market capitalization of ZYLOX-TONBRDG.MED.TECH.H1 from 2021 to today. Between 2021 and today, ZYLOX-TONBRDG.MED.TECH.H1's market cap moved from $967.99 Million to $ 710.87 Million, with a yearly change of -20.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €710.87 Million | -20.34% |
| 2025 | €892.37 Million | +81.54% |
| 2024 | €491.56 Million | -5.11% |
| 2023 | €518.03 Million | -6.80% |
| 2022 | €555.84 Million | -42.58% |
| 2021 | €967.99 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of ZYLOX-TONBRDG.MED.TECH.H1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $708.79 Million USD |
| MoneyControl | $708.79 Million USD |
| MarketWatch | $708.79 Million USD |
| marketcap.company | $708.79 Million USD |
| Reuters | $708.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ZYLOX-TONBRDG.MED.TECH.H1
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracrania… Read more